Form 4 for MAIA MAIA Biotechnology, Inc.
Accepted 2025-12-01 00:00:00 ET · period of report 2025-11-26 · accession 0001878313-25-000056 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-12-01 | 2025-11-26+ | MAIA | Vitoc Vlad | CEO, Dir, 10% | P - Purchase | $1.11 | +72.0K | 881.4K | +9% | +$80.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-26 | P | A | 22,000 | $1.05 | 853,421 | D | — | — | (F2) The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.0145 to $1.0587, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. |
| 2 | Common | Common Stock | 2025-11-28 | P | A | 50,000 | $1.14 | 881,421 | D | — | — | (F1) The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.1283 to $1.1416, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. |